BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saha S, Kapoor S, Tariq R, Schuetz AN, Tosh PK, Pardi DS, Khanna S. Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis. Anaerobe 2019;58:35-46. [PMID: 31330183 DOI: 10.1016/j.anaerobe.2019.102072] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Pu M, Cho JM, Cunningham SA, Behera GK, Becker S, Amjad T, Greenwood-Quaintance KE, Mendes-Soares H, Jones-Hall Y, Jeraldo PR, Chen J, Dunny G, Patel R, Kashyap PC. Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile. Gastroenterology 2021;160:941-945.e8. [PMID: 33197449 DOI: 10.1053/j.gastro.2020.10.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Choi SS, Oh HY, Kim EJ, Lee HK, Kim HK, Choi HH, Kim SW, Chae HS. In Vitro Bactericidal Effects of Photodynamic Therapy Combined with Four Tetracyclines against Clostridioides difficile KCTC5009 in Planktonic Cultures. Pathogens 2020;9:E279. [PMID: 32290477 DOI: 10.3390/pathogens9040279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett 2021;:1-32. [PMID: 34602924 DOI: 10.1007/s10311-021-01274-z] [Reference Citation Analysis]
4 Maraki S, Mavromanolaki VE, Stafylaki D, Kasimati A. Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017–2019. Anaerobe 2020;64:102245. [DOI: 10.1016/j.anaerobe.2020.102245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Garey KW. Perils, Pitfalls, and Promise of Primary Prophylaxis for Clostridioides difficile Infection. Clin Infect Dis 2020;71:1140-1. [PMID: 31560048 DOI: 10.1093/cid/ciz970] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Liu C, Du MX, Abuduaini R, Yu HY, Li DH, Wang YJ, Zhou N, Jiang MZ, Niu PX, Han SS, Chen HH, Shi WY, Wu L, Xin YH, Ma J, Zhou Y, Jiang CY, Liu HW, Liu SJ. Enlightening the taxonomy darkness of human gut microbiomes with a cultured biobank. Microbiome 2021;9:119. [PMID: 34020714 DOI: 10.1186/s40168-021-01064-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Saatchi A, Reid JN, Povitz M, Shariff SZ, Silverman M, Morris AM, Reyes RC, Patrick DM, Marra F. Appropriateness of Outpatient Antibiotic Use in Seniors across Two Canadian Provinces. Antibiotics (Basel) 2021;10:1484. [PMID: 34943696 DOI: 10.3390/antibiotics10121484] [Reference Citation Analysis]
8 Zhou J, Horton JR, Yu D, Ren R, Blumenthal RM, Zhang X, Cheng X. Repurposing epigenetic inhibitors to target the Clostridioides difficile-specific DNA adenine methyltransferase and sporulation regulator CamA. Epigenetics 2021;:1-12. [PMID: 34523387 DOI: 10.1080/15592294.2021.1976910] [Reference Citation Analysis]
9 Sholeh M, Krutova M, Forouzesh M, Mironov S, Sadeghifard N, Molaeipour L, Maleki A, Kouhsari E. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2020;9:158. [PMID: 32977835 DOI: 10.1186/s13756-020-00815-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Saatchi A, Morris AM, Patrick DM, Mccormack J, Reyes RC, Morehouse P, Reid J, Shariff S, Povitz M, Silverman M, Marra F. Outpatient antibiotic use in British Columbia, Canada: reviewing major trends since 2000. JAC Antimicrob Resist 2021;3:dlab116. [PMID: 34396123 DOI: 10.1093/jacamr/dlab116] [Reference Citation Analysis]
11 Dorst A, Gademann K. Chemistry and Biology of the Clinically Used Macrolactone Antibiotic Fidaxomicin. HCA 2020;103. [DOI: 10.1002/hlca.202000038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lew T, Putsathit P, Sohn KM, Wu Y, Ouchi K, Ishii Y, Tateda K, Riley TV, Collins DA. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Antimicrob Agents Chemother 2020;64:e00296-20. [PMID: 32393487 DOI: 10.1128/AAC.00296-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lee HS, Plechot K, Gohil S, Le J. Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis. Infect Dis Ther 2021;10:687-97. [PMID: 33770398 DOI: 10.1007/s40121-021-00417-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Yu L, Palafox-Rosas R, Luna B, She RC. The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against Clostridioides Difficile. Antibiotics (Basel) 2020;9:E684. [PMID: 33050172 DOI: 10.3390/antibiotics9100684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gonzales-Luna AJ, Spinler JK, Oezguen N, Khan MAW, Danhof HA, Endres BT, Alam MJ, Begum K, Lancaster C, Costa GP, Savidge TC, Hurdle JG, Britton R, Garey KW. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe 2021;70:102387. [PMID: 34044101 DOI: 10.1016/j.anaerobe.2021.102387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Poylin V, Hawkins AT, Bhama AR, Boutros M, Lightner AL, Khanna S, Paquette IM, Feingold DL; Prepared by the Clinical Practice Guidelines Committee of The American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection. Dis Colon Rectum 2021;64:650-68. [PMID: 33769319 DOI: 10.1097/DCR.0000000000002047] [Reference Citation Analysis]
17 Boekhoud IM, Sidorov I, Nooij S, Harmanus C, Bos-Sanders IMJG, Viprey V, Spittal W, Clark E, Davies K, Freeman J, Kuijper EJ, Smits WK; COMBACTE-CDI Consortium. Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile. J Antimicrob Chemother 2021;76:1731-40. [PMID: 33876817 DOI: 10.1093/jac/dkab097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 O’grady K, Knight DR, Riley TV. Antimicrobial resistance in Clostridioides difficile. Eur J Clin Microbiol Infect Dis. [DOI: 10.1007/s10096-021-04311-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Khanna S, Tande A, Rubin DT, Khoruts A, Kahn SA, Pardi DS. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations. Mayo Clin Proc 2021;96:1418-25. [PMID: 34088413 DOI: 10.1016/j.mayocp.2021.04.005] [Reference Citation Analysis]
20 Saha S, Kapoor S, Tariq R, Schuetz AN, Tosh PK, Pardi DS, Khanna S. Response to 'Comments on the published systematic review and meta-analysis on the increasing antibiotic resistance in Clostridioides difficile' by Kouhsari et al. Anaerobe 2020;61:102148. [PMID: 31968234 DOI: 10.1016/j.anaerobe.2020.102148] [Reference Citation Analysis]
21 Karlowsky JA, Adam HJ, Baxter MR, Dutka CW, Nichol KA, Laing NM, Golding GR, Zhanel GG. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017. Journal of Antimicrobial Chemotherapy 2020;75:1824-32. [DOI: 10.1093/jac/dkaa118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Hofmann JD, Biedendieck R, Michel AM, Schomburg D, Jahn D, Neumann-Schaal M. Influence of L-lactate and low glucose concentrations on the metabolism and the toxin formation of Clostridioides difficile. PLoS One 2021;16:e0244988. [PMID: 33411772 DOI: 10.1371/journal.pone.0244988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]